Serum N-terminal-pro-B-type natriuretic peptide (NT-pro-BNP) levels in hyperthyroidism and hypothyroidism

Endocrine Research

Volumn 32, Issue 1-2, 2006, Pages 1-8

  Özmen, Bilgin ^a   Özmen, Dilek ^b   Parildar, Zuhal ^b   Mutaf, Işil ^b   Bayindir, Oya ^b  

^a CELAL BAYAR UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; THYROID HORMONE; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76); THYROTROPIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROIMMUNOASSAY; FEMALE; HEART RATE; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; AGED; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; HEART RATE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; THYROID HORMONES; THYROTROPIN;

EID: 40449107937     PISSN: 07435800     EISSN: 15324206     Source Type: Journal    
DOI: 10.1080/07435800701670047     Document Type: Article

References (25)

1. Danzi, S., Klein, I. Thyroid hormone and the cardiovascular system. Minerva Endocrinol 2004; 29:139-50.
2. Dorr, M., Voltzke, H. Cardiovascular morbidity and mortality in thyroid dysfunction. Minerva Endocrinol 2005; 30:199-216.
3. Kahaly, G.J., Dillmann, W.H. Thyroid hormone action in the heart. End Rev 2005; 26:704-728.
4. Dorr, M., Wolff, B., Robinson, D.M., John, U., Ludemann, J., Meng, W., Felix, S.B., Volzke, H. The association of thyroid function with cardiac mass and left ventricular hypertrophy. J Clin Endocrinol Metab 2005; 90:673-7.
5. Klein, I., Ojamaa, K. Thyroid hormone and the cardiovascular system. N Eng J Med 2001; 344:501-9.
6. Polikar, R., Burger, A.G., Scherrer, U., Nicod, P. The thyroid and the heart. Circulation 1993; 87: 1435-1441.
7. Tang, Y.D., Kuzman, J.A., Said, S., Anderson, B.E., Wang, X., Gerdes, M. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation 2005; 112:3122-3130.
8. Latour-Perez, J., Coves-Orts, F.J., Abad-Terrado, C., Abraira, V., Zamora, J. Accuracy of B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction and heart failure: a systematic review. Eur J Heart Fail 2006; 8:390-9.
9. Nielsen, L.S., Svanegaard, J., Klitgaard, N.A., Egeblad, H. N-terminal pro-brain natriuretic peptide for discriminating between cardiac and non-cardiac dyspnea. Eur J Heart Fail 2004; 6:63-70.
10. Hall, J. Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 2004; 6:257-260.
11. Downie, P.F., Talwar, S., Squire, I.B., Davies, J.E., Barnett, D.B., Ng, L.L. Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro : implications for assessment of left ventricular dysfunction. Clin Sci (Lond) 1999; 97:255-8.
12. Karl, J., Borgya, A., Gallusser, A., Huber, E., Krueger, K., Rollinger, W., Schenk, J. Development of a novel, N-terminal -proBNP (NT-proBNP) assay with a low detection limit. Scand J Clin Lab Invest Suppl 1999; 230:177-181.
13. Liang, F., Webb, P., Marimuthu, A., Zhang, S., Gardner, D.G. Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endothelin-dependent BNP gene transcription and hypertrophy in neonatal rat ventricular myocytes. J Biol Chem 2003; 278:15073-83.
14. Bernstein, R., Midtbo, K., Urdal, P., Morkrid, L., Smith, G., Muller, C., Bjoro, T., Haug, H. Serum N-terminal pro-atrial factor 1-98 before and during thyroxine replacement theraphy in severe hypothyroidism. Thyroid 1997; 7:415-9.
15. Diekman, M.J., Harms, M.P., Endert, E., Wieling, W., Wiersinga, W.M. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroidic patients. Eur J Endocrinol 2001; 144:339-46.
16. Schultz, M., Faber, J., Kistorp, C., Jarlov, A., Pedersen, F., Wiinberg, N., Hildebrandt, P. N-terminal-pro-B-type natriuretic peptid (NT-proBNP) in different thyroid states. Clin Endocrinol (Oxf) 2004; 60:54-59.
17. Christ-Crain, M., Morgenthaler, N.G., Meier, C., Müller, C., Nussbaumer, C., Bergmann, A., Staub, J.J., Müller, B. Pro-A-type and N-terminal pro-B-type natriuretic peptides in different thyroid function states. Swiss Med Wkly 2005; 135(37-38):549-54.
18. Wei, T., Zeng, C., Tian, Y., Chen, Q., Wang, L. B-type natriuretic peptide in patients with clinical hyperthyroidism. J Endocrinol Invest 2005; 28:8-11.
19. Manuchehri, A.M., Jayagopal, V., Kilpatrick, E.S., Atkin, S.L. The effect of thyroid dysfunction on N-terminal pro-B-type natriuretic peptide concentrations. Ann Clin Biochem 2006; 43:184-8.
20. Kohno, M., Horio, T., Yasunari, K., Yokokawa, K., Ikeda, M., Kurihara, N., Nishizawa, Y., Morii, H., Takede, T. Stimulation of brain natriuretic peptide release from the heart by thyroid hormone. Metabolism 1993; 42:1059-64.
21. Levey, G.S., Klein, I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med 1990; 88:642-6.
22. Hoit, B.D., Khoury, S.F., Shao, Y., Gabel, M., Linggett, S.B., Walsh, R.A. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation 1997; 96:592-8.
23. Ojamaa, K., Klein, I., Sabet, A., Steinberg, S.F. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism 2000; 49:275-9.
24. Shimoike, H., Iwai, N., Kinoshita, M. Different regulation of natriuretic peptide genes in infracted rat hearts. Clin Exp Pharmacol Physiol 1997; 24:23-30.
25. Mair, J., Friedl, W., Thomas, S., Puschendorf, B. Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest 1999; 59:132-142.